These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27579548)

  • 1. Cardiovascular polypill: time to rethink?
    Bondugulapati LN
    Curr Opin Lipidol; 2016 Oct; 27(5):537-8. PubMed ID: 27579548
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Polypill - A Practicable Approach?].
    Thürmann PA; Kleinerüschkamp AG; Boehme P
    Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypill for cardiovascular disease prevention.
    Dalton AR
    JAMA; 2013 Aug; 310(7):749. PubMed ID: 23989135
    [No Abstract]   [Full Text] [Related]  

  • 4. Polypill for cardiovascular disease prevention--reply.
    Smith R; McCready T; Yusuf S
    JAMA; 2013 Aug; 310(7):749-50. PubMed ID: 23989317
    [No Abstract]   [Full Text] [Related]  

  • 5. Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?
    Chao J; Bansilal S
    Glob Heart; 2016 Dec; 11(4):469-472. PubMed ID: 27938845
    [No Abstract]   [Full Text] [Related]  

  • 6. Polypill in cardiovascular disease: has it's time come?
    Kuppuswamy V; Choo WK; Gupta S
    Indian Heart J; 2009; 61(4):322-7. PubMed ID: 20635733
    [No Abstract]   [Full Text] [Related]  

  • 7. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?
    Franczyk B; Gluba-Brzózka A; Jurkiewicz Ł; Penson P; Banach M; Rysz J
    Expert Opin Pharmacother; 2018 Dec; 19(17):1857-1865. PubMed ID: 30295098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE; Bots ML; Stanton A; Patel A; Prabhakaran D; Webster R; Thom S; Rodgers A;
    Eur J Prev Cardiol; 2017 Jun; 24(9):951-961. PubMed ID: 28436727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving cardiovascular protection: focus on a cardiovascular polypill.
    Barrios V; Escobar C
    Future Cardiol; 2016 Mar; 12(2):181-96. PubMed ID: 26652213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis.
    Zomer E; Owen A; Magliano DJ; Ademi Z; Reid CM; Liew D
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):121-8. PubMed ID: 23532687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panacea in a pill?
    Amsterdam EA
    Prev Cardiol; 2004; 7(1):46-7. PubMed ID: 15010628
    [No Abstract]   [Full Text] [Related]  

  • 14. The polypill and medicines access: two decades and counting.
    Rodgers A; Smith R
    BMJ; 2023 Aug; 382():1847. PubMed ID: 37562792
    [No Abstract]   [Full Text] [Related]  

  • 15. [The polypill: not an effective strategy for reduction of cardiovascular disease].
    Westerweel PE; van Wijk JP; Verhaar MC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One Pill for Everyone? Twenty Years of Polypill for Cardiovascular Disease.
    Tran RJC
    Am J Cardiol; 2023 Sep; 203():493-495. PubMed ID: 37500317
    [No Abstract]   [Full Text] [Related]  

  • 17. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
    Joshi SR
    J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
    [No Abstract]   [Full Text] [Related]  

  • 18. The polypill: from concept and evidence to implementation.
    Yusuf S; Pinto FJ
    Lancet; 2022 Nov; 400(10364):1661-1663. PubMed ID: 36243022
    [No Abstract]   [Full Text] [Related]  

  • 19. Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy.
    Castellano JM; Fuster V
    Rev Esp Cardiol (Engl Ed); 2023 Dec; 76(12):1055-1060. PubMed ID: 37866619
    [No Abstract]   [Full Text] [Related]  

  • 20. Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed Care.
    Ebell MH
    Am Fam Physician; 2023 Mar; 107(3):318-319. PubMed ID: 36920802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.